EX-2.1 2 ebig_ex21.htm AGREEMENT AND PLAN OF MERGER ebig_ex21.htm
EXHIBIT 2.1
 
AMENDMENT NO. 1 TO
AGREEMENT AND PLAN OF MERGER
 
This AMENDMENT NO. 1 to AGREEMENT AND PLAN OF MERGER (“Amendment”) dated January 15, 2013 is an amendment to that certain Agreement and Plan of Merger ("Merger Agreement") dated November 13, 2012, by and among EastBridge Investment Group Corporation, an Arizona corporation (“Parent”), CBMG Acquisition Limited, a business company with limited liability incorporated under the laws of the British Virgin Islands, all of the outstanding shares of which are owned by the Parent (“Merger Sub”), and Cellular Biomedicine Group Ltd., a business company with limited liability incorporated under the laws of the British Virgin Islands (the “Company”).

Section 2.2 of the Merger Agreement is hereby amended such that the Drop Dead Date shall be January 31, 2013.

IN WITNESS WHEREOF, this Amendment has been duly executed and delivered by the duly authorized officers of the parties hereto as of the date first written above.
 
COMPANY:
 
CELLULAR BIOMEDICINE GROUP LIMITED
 
     
By:
/s/ Wen Tao Liu  
Name:  Wen Tao Liu  
Title: Chairman and Chief Executive Officer  
     
     
PARENT:  
     
EASTBRIDGE INVESTMENT GROUP CORPORATION  
     
By:
/s/ Norman P. Klein  
Name:  Norman P. Klein  
Title: Chief Operating Officer and Chief Financial Officer  
     
     
MERGER SUB:  
     
CBMG ACQUISITION LIMITED  
     
By:
/s/ Norman P. Klein  
Name:  Norman P. Klein  
Title: President